1. Home
  2. GKOS vs TXT Comparison

GKOS vs TXT Comparison

Compare GKOS & TXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$115.81

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Textron Inc.

TXT

Textron Inc.

HOLD

Current Price

$90.20

Market Cap

14.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
TXT
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
14.5B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
TXT
Price
$115.81
$90.20
Analyst Decision
Strong Buy
Buy
Analyst Count
13
12
Target Price
$126.38
$92.33
AVG Volume (30 Days)
694.2K
1.4M
Earning Date
10-29-2025
01-21-2026
Dividend Yield
N/A
0.09%
EPS Growth
N/A
N/A
EPS
N/A
4.55
Revenue
$469,820,000.00
$14,237,000,000.00
Revenue This Year
$31.15
$8.63
Revenue Next Year
$24.15
$4.98
P/E Ratio
N/A
$19.82
Revenue Growth
30.38
1.83
52 Week Low
$73.16
$57.70
52 Week High
$163.71
$91.22

Technical Indicators

Market Signals
Indicator
GKOS
TXT
Relative Strength Index (RSI) 71.98 68.66
Support Level $115.07 $85.62
Resistance Level $117.94 $91.22
Average True Range (ATR) 2.91 1.60
MACD -0.13 0.41
Stochastic Oscillator 81.29 86.92

Price Performance

Historical Comparison
GKOS
TXT

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About TXT Textron Inc.

Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.

Share on Social Networks: